For citations:

Proshchai G.I., Dudarenko S.V., Partcerniak A.S., Zagarskikh E.Yu., Partcerniak S.A. Fibroblast growth factor 21 from the perspective of a promising marker of metabolic disorders and premature aging in polymorbid cardiovascular pathology in young and middle-aged people. Emergency Cardiology and Cardiovascular Risks journal. 2020;4(2):1002–1005. (In Russ.)